Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease
16 de março de 2021 atualizado por: Habibedurdu
The Effect of Pectoralis Muscle Strength on Pulmonary Function in Elderly With Interstitial Lung Disease
Interstitial lung disease (ILD) is a restrictive lung disease characterized by impaired lung function, exercise limitation and skeletal muscle dysfunction.
There is limited data on skeletal muscle function in ILD, most of which are focused on the lower limb muscles.
The aim of this study were to evaluated the change of pectoralis muscle strength and relationship of pulmonary function with pectoralis muscle strength.
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Descrição detalhada
This study consisted of intervention and control groups.
Thirty one patients with ILD were included in the patient's group and 37 healthy volunteers in the control group.
All participants were selected from the geriatric population.
Demographic and cardiopulmonary physiotherapy assessment of all participants were performed.
Lung function test, maximal inspiratory and expiratory pressure and pectoralis muscle strength were measured in participants of both groups.
All measurements were performed once.
Tipo de estudo
Observacional
Inscrição (Real)
68
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Giresun, Peru
- Giresun University
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
65 anos a 85 anos (Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Método de amostragem
Amostra Não Probabilística
População do estudo
The patient's group was selected from among the patients who applied to Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital.
The control group was selected among volunteers invited from the local community.
Descrição
Inclusion Criteria:
- Diagnosed with ILD by a multidisciplinary team according to the 2011 ATS/ERS guidelines for ILD
- Aged 65-85
Exclusion Criteria:
- Uncontrolled/active cardiovascular, metabolic, systemic or cancerous disease
- Significant orthopedic, neurologic or musculoskeletal comorbidity that limited functional independence
- No being able to cooperate
- Refuse to participate in the current study
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Modelos de observação: Controle de caso
- Perspectivas de Tempo: Prospectivo
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Patient's group
geriatric patients with interstitial lung disease
|
In both groups, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1 / FVC ratio were measured with portable spirometer according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
Maximal inspiratory (MIP) and expiratory pressure (MEP) were evaluated with mouth pressure device as per ATS/ERS guidelines.
Sensation of dyspnea was assessed with Modified medical council research scale.
Pectoralis muscle strength were measured isometrically using with digital hand held dynamometer.
|
|
Control group
healthy volunteers selected from the geriatric population
|
In both groups, forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and FEV1 / FVC ratio were measured with portable spirometer according to the guidelines of the American Thoracic Society (ATS) and the European Respiratory Society (ERS).
Maximal inspiratory (MIP) and expiratory pressure (MEP) were evaluated with mouth pressure device as per ATS/ERS guidelines.
Sensation of dyspnea was assessed with Modified medical council research scale.
Pectoralis muscle strength were measured isometrically using with digital hand held dynamometer.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pectoralis muscle strength test
Prazo: 15 minute
|
The pectoralis muscle strength were measured with handheld dynamometer in supine position.
The shoulder joint of participant was positioned at 90º abducted and at 0º internal/external rotation and the elbow joint was flexed at 90º.
The other shoulder joint was fixed by the physiotherapist.
While the participant performed isometrically horizontal adduction movement, the measurement was performed on the distal part of the upper arm and the contraction was sustained for at least 5 seconds by the participant.
The test was performed three times and with 60 seconds rest between tests.
The mean of the best value on both sides was recorded.
|
15 minute
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
FEV1
Prazo: 5 minute
|
FEV1 value was measured with portable spirometer according to ATS/ ERS guidelines for pulmonary function test.
Results of the measurements were recorded as percentanges of predicted values.
|
5 minute
|
|
FVC
Prazo: 5 minute
|
FVC value was measured with portable spirometer according to ATS/ ERS guidelines for pulmonary function test.
Results of the measurements were recorded as percentanges of predicted values.
|
5 minute
|
|
FEV1/FVC
Prazo: 5 minute
|
The ratio of FEV1/FVC was calculated by measuring device according to measured FEV1 and FVC values
|
5 minute
|
|
Respiratory muscle strength test
Prazo: 15 minute
|
Maximal mouth pressures were measured to evaluate respiratory muscle strength.
The test was performed with mouth pressure device in sitting position.
Participants breathed through a flanged mouthpiece inside the lips at near residual volume for the MIP value and near total lung capacity for MEP value .
The maximum effort was sustained for at least one second.
The test was repeated at least 3 times until no more than 10% difference was present between highest and previous measurements .
The higest value and percentage value of predicted highest value were recorded
|
15 minute
|
|
Dyspnea assessment
Prazo: 3 minute
|
Modified Medical Council Research Dyspnea scale were used to assess sensation of dyspnea
|
3 minute
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Habibe DURDU, MSc, Giresun University
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Publicações Gerais
- Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
- Hirano M, Katoh M, Kawaguchi S, Uemura T. Intrarater reliabilities of shoulder joint horizontal adductor muscle strength measurements using a handheld dynamometer for geriatric and stroke patients. J Phys Ther Sci. 2016 Jan;28(1):51-5. doi: 10.1589/jpts.28.51. Epub 2016 Jan 30.
- Panagiotou M, Polychronopoulos V, Strange C. Respiratory and lower limb muscle function in interstitial lung disease. Chron Respir Dis. 2016 May;13(2):162-72. doi: 10.1177/1479972315626014. Epub 2016 Jan 14.
- Hanada M, Sakamoto N, Ishimatsu Y, Kakugawa T, Obase Y, Kozu R, Senjyu H, Izumikawa K, Mukae H, Kohno S. Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease. Respirology. 2016 Aug;21(6):1088-93. doi: 10.1111/resp.12807. Epub 2016 May 13.
- Durdu H, Yurdalan SU, Ozmen I. Clinical significance of pectoralis muscle strength in elderly patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(1):e2022009. doi: 10.36141/svdld.v39i1.12094. Epub 2022 Mar 31.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
23 de janeiro de 2017
Conclusão Primária (Real)
23 de junho de 2017
Conclusão do estudo (Real)
23 de junho de 2017
Datas de inscrição no estudo
Enviado pela primeira vez
13 de março de 2021
Enviado pela primeira vez que atendeu aos critérios de CQ
16 de março de 2021
Primeira postagem (Real)
17 de março de 2021
Atualizações de registro de estudo
Última Atualização Postada (Real)
17 de março de 2021
Última atualização enviada que atendeu aos critérios de controle de qualidade
16 de março de 2021
Última verificação
1 de março de 2021
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Pectoralismajor
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Não
Descrição do plano IPD
The data sets collected and analyzed during this study could be provided from corresponding author upon reasonable request
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .